Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 23, Issue 7, 2003, Pages 1218-1223

  Desideri, Giovambattista ^a   Bravi, Maria Cristina ^b   Tucci, Marzia ^b   Croce, Giuseppe ^b   Marinucci, Maria Contina ^b   Santucci, Anna ^b   Alesse, Edoardo ^a   Ferri, Claudio ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Dept of Int Med and Public Health ^*

Author keywords

Angiotensin II; Endothelium; Glutathione; Migration; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN I; ANTIOXIDANT; CANDESARTAN HEXETIL; DIPHENYLIODONIUM SALT; GLUTATHIONE REDUCTASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZING AGENT; REACTIVE OXYGEN METABOLITE;

ARTICLE; BLOOD VESSEL WALL; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; DRUG POTENTIATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; CELL DIVISION; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GLUTATHIONE; HUMANS; NADPH OXIDASE; NITRIC OXIDE; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TETRAZOLES; TIME FACTORS;

EID: 0038448049     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000078521.51319.65     Document Type: Article

References (31)

1. Coomber BL, Gotlieb AI. In vitro endothelial wound repair: interaction of cell migration and proliferation. Arteriosclerosis. 1990;10:215-222.
2. Schwartz SM, Haudenschild CC, Eddy EM. Endothelial regeneration I: quantitative analysis of initial stages of endothelial regeneration in rat aortic intima. Lab Invest. 1978;38:568-580.
3. Reidy MA, Schwartz SM. Endothelial regeneration, III: time course of intimal changes after small defined injury to rat aortic endothelium. Lab Invest. 1981;44:301-308.
4. Casscells W. Migration of smooth muscle and endothelial cells: critical events in restenosis. Circulation. 1992;86:723-729.
5. Dzau VJ. Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension. 2001;37:1047-1052.
6. Bell L, Madri JA. Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol. 1990;137:7-12.
7. c-src expression. J Clin Invest. 1992;89:315-320.
8. Romero JC, Reckelhoff JF. Role of angiotensin and oxidative stress in essential hypertension. Hypertension. 1999;34(part 2):943-949.
9. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
10. Touyz RM, Schiffrin EL. Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension. 1999;34(part 2):976-982.
11. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol. 1995;268: L698-K722.
12. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T, Harrison DG. Endothelial regulation of vasomotion in apo E-deficient mice: implications for interaction between peroxynitrite and tetrahydrobiopterin. Circulation. 2001;103:282-1288.
13. Desideri G, Ferri C, Bellini C, De Mattia G, Santucci A. Effects of ACE inhibition on spontaneous and insulin-stimulated endothelin-1 secretion. Diabetes. 1997;46:81-86.
14. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical cord veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52: 2745-2756.
15. Bravi MC, Pietrangeli P, Laurenti O, Basili S, Cassone-Faldetta M, Ferri C, De Mattia G. Poliol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients. Metabolism. 1997;46:1194-198.
16. De Mattia G, Bravi MC, Laurenti O, Cassone-Faldetta M, Proietti A, De Luca O, Armento A, Ferri C. Reduction of oxidative stress by oral N-acetyl-L-cysteine treatment decreases plasma soluble vascular cell adhesion molecule-1 concentrations in non-obese, non-dyslipidemic, normotensive patients with non-insulin, dependent diabetes. Diabetologia. 1998;41:1392-1396.
17. Anderson ME. Determination of glutathione and glutathione disulfide in biological samples. Method Enzymol. 1987;113:548-555.
18. Wu L, Juurlink BH. The impaired glutathione system and its up-regulation by sulforaphane in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens. 2001;19:1819-1825.
19. Thorburne SK, Juurlink BH. Low glutathione and high iron govern the susceptibility of oligodendroglial precursor to oxidative stress. J Neurochem. 1996;67:1014-1022.
20. Kajio T, Kawahara K, Kato K. Quantitative colorimetric assay for basic fibroblast growth factor using bovine endothelial cells and heparin. J Pharmacol Toxicol Methods. 1992;28:9-14.
21. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, Sullivan A, Losordo DW, Isner JM. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol. 1999;19:1156-1161.
22. Beckman JS, and Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol. 1996;271: C1424-C1437.
23. Urbich C, Reissner A, Chavakis E, Dernbach E, Haendeler J, Fleming I, Zeiher AM, Kaszkin M, Dimmeler S. Dephosphorylation of endothelial nitric oxide synthase contributes to the anti-angiogenic effects of endostatin. FASEB J. 2002;16:706-708.
24. Bloodsworth A, O'Donnell AB, Freeman BA. Nitric oxide regulation of free-radical- and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler Thromb Vasc Biol. 2000;20:1707-1715.
25. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Bernini G, Magagna A, Salvetti A. Age related reduction of NO availability and oxidative stress in humans. Hypertension. 2001;38:274-279.
26. Maytin M, Leopold J, Loscalzo J. Oxidant stress in the vasculature. Curr Atheroscler Rep. 1999;1:156-164.
27. Ambrosio G, Tritto I, Golino P. Reactive oxygen metabolites and arterial thrombosis. Cardiovasc Res. 1997;34:445-452.
28. Pueyo ME, Gonzales W, Nicoletti A, Savoie F, Arnal JF, Michel JB. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-κB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol. 2000;20:645-651.
29. Stühlinger MC, Tsao PS, Her JH, Kimoto M, Balint RF, Cooke JP. Homocysteine impairs the nitric oxide synthase pathway. Role of asymmetric dimethylarginine. Circulation. 2001;104:2569-2575.
30. Touyz RM, Schiffrin EL. Increase generation of superoxide angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens. 2001;19:1245-1254.
31. Urbich A, Dernbach E, Aicher A, Zeiher A, Dimmeler S. CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation. 2002;106:981-986.